Murat Calapkulu

Dr. Murat Calapkulu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMuhammed Erkam Sencar
Muhammed Erkam Sencar
MCMurat Calapkulu
Murat Calapkulu
DSDavut Sakiz
Davut Sakiz
SHSema Hepsen
Sema Hepsen
AKArif Kus
Arif Kus
ECErman Cakal
Erman Cakal
Subacute thyroiditis (SAT) is an inflammatory thyroid disease. The main purpose of the treatment is to relieve pain and control the inflammatory process. The aim of the present study was to evaluate the therapeutic effects of steroid and non-steroidal anti-inflammatory drugs (NSAIDs) in SAT. Initial laboratory data, treatment response, and long-term results of 295 SAT patients treated with ibuprofen or methylprednisolone were evaluated. After the exclusion of 78 patients, evaluation was made of 126 patients treated with 1800 mg ibuprofen and 91 patients treated with 48 mg methylprednisolone. In 59.5% of 126 patients treated with ibuprofen, there was no adequate clinical response at the first control visit. In 54% of patients, the treatment was changed to steroids in mean 9.5 days. Symptomatic remission was achieved within two weeks in all patients treated with methylprednisolone. The total recurrence rate was 19.8%, and recurrences were observed more frequently in patients receiving only steroid therapy than in patients treated with NSAID only (23% vs. 10.5% p:0.04). Persistent hypothyroidism developed in 22.8% of patients treated only with ibuprofen and in 6.6% of patients treated with methylprednisolone only. Treatment with only ibuprofen (p:0.039) and positive thyroid peroxidase antibody (anti-TPO) (p:0.029) were determined as the main risk factors for permanent hypothyroidism. NSAID treatment is not as effective as steroid treatment in early clinical remission. Steroid treatment was detected as a protective factor against permanent hypothyroidism. Therefore, steroid therapy may be considered especially in anti-TPO positive SAT patients and patients with high-level acute phase reactants.

1 March 2019 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MCMurat Calapkulu
Murat Calapkulu
SCSoner Cander
Soner Cander
OGOzen Oz Gul
Ozen Oz Gul
CECanan Ersoy
Canan Ersoy

21 December 2019 in Endocrine
Verified
Journal Article
Closed access
PDF file
MCMurat Calapkulu
Murat Calapkulu
MSMuhammed Erkam Sencar
Muhammed Erkam Sencar
DSDavut Sakiz
Davut Sakiz
HDHakan Duger
Hakan Duger
IUIlknur Ozturk Unsal
Ilknur Ozturk Unsal
ECErman Cakal
Erman Cakal

25 April 2023 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
ABAdnan Batman
Adnan Batman
DYDilek Yazıcı
Dilek Yazıcı
ODOğuz Dikbaş
Oğuz Dikbaş
KAKemal Ağbaht
Kemal Ağbaht
ESEmre Sedar Saygılı
Emre Sedar Saygılı
MSMustafa - Sahin
Mustafa - Sahin
Context: The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism. Methods: This nationwide, multicenter, retrospective cohort study included 53 endocrinology centers in Turkey. The study participants were divided into either COVID-19–related SAT (Cov-SAT), SARS-CoV-2 vaccine–related SAT (Vac-SAT), or control SAT (Cont-SAT) groups. Results: Of the 811 patients, 258 (31.8%) were included in the Vac-SAT group, 98 (12.1%) in the Cov-SAT group, and 455 (56.1%) in the Cont-SAT group. No difference was found between the groups with regard to laboratory and imaging findings. SAT etiology was not an independent predictor of recurrence or hypothyroidism. In the entire cohort, steroid therapy requirement and younger age were statistically significant predictors for SAT recurrence. C-reactive protein measured during SAT onset, female sex, absence of antithyroid peroxidase (TPO) positivity, and absence of steroid therapy were statistically significant predictors of incident (early) hypothyroidism, irrespective of SAT etiology. On the other hand, probable predictors of established hypothyroidism differed from that of incident hypothyroidism. Conclusion: Since there is no difference in terms of follow-up parameters and outcomes, COVID-19– and SARS-CoV-2 vaccine–related SAT can be treated and followed up like classic SATs. Recurrence was determined by younger age and steroid therapy requirement. Steroid therapy independently predicts incident hypothyroidism that may sometimes be transient in overall SAT and is also associated with a lower risk of established hypothyroidism.

5 June 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MSMuhammed Erkam Sencar
Muhammed Erkam Sencar
MCMurat Calapkulu
Murat Calapkulu
DSDavut Sakiz
Davut Sakiz
PAPinar Akhanli
Pinar Akhanli
SHSema Hepsen
Sema Hepsen
ECErman Cakal
Erman Cakal
Key words: Subacute thyroiditis; ultrasonography; prognosis; permanent hypothyroidism

30 April 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
İÜİlknur Öztürk Ünsal
İlknur Öztürk Ünsal
SHSema Hepsen
Sema Hepsen
PAPınar Akhanli
Pınar Akhanli
MCMurat Calapkulu
Murat Calapkulu
MSMuhammed Erkam Sencar
Muhammed Erkam Sencar
ECErman Cakal
Erman Cakal
Autoimmune thyroid disease in women is associated with subfertility and early pregnancy loss, and patients with primary ovarian insufficiency have a high prevalence of thyroid autoimmune disorders. The aim of this study was to investigate the association between Hashimoto thyroiditis (HT) and ovarian reserve. Levels of serum thyroid stimulating hormones, thyroid autoantibodies, and anti-Müllerian hormone (AMH) were measured in women with HT and a healthy control group between 2018 and 2019. Evaluation was made of 108 premenopausal women with HT, and a control group of 172 healthy females with normal anti-thyroid antibody levels and thyroid function. Serum AMH levels were determined to be significantly lower in the HT group compared to the control group. Ovarian reserve evaluated by serum AMH concentration is affected by thyroid autoimmunity independently of anti-thyroid antibodies type or titers.